Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
Mice
Autophagy
KNOCKOUT MICE
DMSXL mice
Brain
Myotonic dystrophy type 1
Exercise
Gene Therapy
Cell model
Therapy
Central nervous system
Dystrophie Myotonique
Glial cells
Alternative splicing
Gene therapy
Humans
PacBio
Gene editing
Heart failure
Cytoskeleton
Animals
Oligodendrocyte
CONGENITAL MYATHENIC SYNDROME
Maximal force
Trinucleotide Repeat Expansion
Thérapie génique
Transgenic mouse model
Myotonic Dystrophy type 1
Antisense oligonucleotides
ARN
Cardiac muscle
Centronuclear myopathy
Mouse models
Desmin
In vivo
Quantitative microdialysis
PCR
CRISPR/Cas9
Diaphragm
MBNL
GABA
Cell culture model
CTG repeats
Skeletal muscle
Exercice
Myotonic Dystrophy Type 1
Cell penetrating peptide
Transgenic mouse
Astrocyte
Myostatin
Intermediate filament
Expression
Heart
Glucocorticoids
Endurance training
Astrocytes
DM1
BIOLOGIE MOLECULAIRE
Glucocorticoid-receptor
GSK3
Myotonic Dystrophy
RNA interference
Dystrophin
CMS
Glutamate
Acute coronary syndrome
Hypoxia
Myotonic dystrophy mouse models
Duchenne muscular dystrophy
Motoneuron
Aging
Myotonic dystrophy
Dystrophie myotonique
ACETYLCHOLINESTERASE
RNA biology
Acetylcholinesterase deficiency
Dynamin 2
Muscle
Genotype phenotype correlation
Fibrosis
AAV
Acetylcholinesterase knockout mouse
Brain dysfunction
Antisense oligonucleotide
CTG repeat contractions
Neuron
DMPK
Oligodendrocytes
Transcriptomics
Long read sequencing
Knockout
Muscular dystrophy
Trinucleotide repeat expansion
Myelin
Male
RNA splicing
CRISPRi
Dilated cardiomyopathy
CTG repeat instability
Mouse model